Stijn De Buck1,2,3,4,5, Alexander Van De Bruaene6,7,8, Werner Budts6,7, Paul Suetens9,8. 1. Imaging & Pathology Department, KU Leuven, Herestraat 49, BUS 7003, 3000, Leuven, Belgium. stijn.debuck@uzleuven.be. 2. ESAT, KU Leuven, Herestraat 49, BUS 7003, 3000, Leuven, Belgium. stijn.debuck@uzleuven.be. 3. Radiology Department, UZ Leuven, Herestraat 49, 3000, Leuven, Belgium. stijn.debuck@uzleuven.be. 4. Cardiology Department, UZ Leuven, Herestraat 49, 3000, Leuven, Belgium. stijn.debuck@uzleuven.be. 5. Medical Imaging Research Center, KU Leuven, Herestraat 49, BUS 7003, 3000, Leuven, Belgium. stijn.debuck@uzleuven.be. 6. Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. 7. Congenital and Structural Cardiology, UZ Leuven, Herestraat 49, 3000, Leuven, Belgium. 8. Medical Imaging Research Center, KU Leuven, Herestraat 49, BUS 7003, 3000, Leuven, Belgium. 9. ESAT, KU Leuven, Herestraat 49, BUS 7003, 3000, Leuven, Belgium.
Abstract
PURPOSE: Virtual reality (VR) can provide an added value for diagnosis and/or intervention planning. Several VR software implementations have been proposed but they are often application dependent. Previous attempts for a more generic solution incorporating VR in medical prototyping software (MeVisLab) were still lacking functionality precluding easy and flexible development. METHODS: We propose an alternative solution that uses rendering to a graphical processing unit (GPU) texture to enable rendering arbitrary Open Inventor scenes in a VR context. It facilitates flexible development of user interaction and rendering of more complex scenes involving multiple objects. We tested the platform in planning a transcatheter cardiac stent placement procedure. RESULTS: This approach proved to enable development of a particular implementation that facilitates planning of percutaneous treatment of a sinus venosus atrial septal defect. The implementation showed it is intuitive to plan and verify the procedure using VR. CONCLUSION: An alternative implementation for linking OpenVR with MeVisLab is provided that offers more flexible development of VR prototypes which can facilitate further clinical validation of this technology in various medical disciplines.
PURPOSE: Virtual reality (VR) can provide an added value for diagnosis and/or intervention planning. Several VR software implementations have been proposed but they are often application dependent. Previous attempts for a more generic solution incorporating VR in medical prototyping software (MeVisLab) were still lacking functionality precluding easy and flexible development. METHODS: We propose an alternative solution that uses rendering to a graphical processing unit (GPU) texture to enable rendering arbitrary Open Inventor scenes in a VR context. It facilitates flexible development of user interaction and rendering of more complex scenes involving multiple objects. We tested the platform in planning a transcatheter cardiac stent placement procedure. RESULTS: This approach proved to enable development of a particular implementation that facilitates planning of percutaneous treatment of a sinus venosus atrial septal defect. The implementation showed it is intuitive to plan and verify the procedure using VR. CONCLUSION: An alternative implementation for linking OpenVR with MeVisLab is provided that offers more flexible development of VR prototypes which can facilitate further clinical validation of this technology in various medical disciplines.
Authors: Justin Sutherland; Jason Belec; Adnan Sheikh; Leonid Chepelev; Waleed Althobaity; Benjamin J W Chow; Dimitrios Mitsouras; Andy Christensen; Frank J Rybicki; Daniel J La Russa Journal: J Digit Imaging Date: 2019-02 Impact factor: 4.056
Authors: Pia Vayssiere; Paul E Constanthin; Bruno Herbelin; Olaf Blanke; Karl Schaller; Philippe Bijlenga Journal: J Clin Neurosci Date: 2021-12-05 Impact factor: 1.961
Authors: Jan Hinnerk Hansen; Phuoc Duong; Salim G M Jivanji; Matthew Jones; Saleha Kabir; Gianfranco Butera; Shakeel A Qureshi; Eric Rosenthal Journal: J Am Coll Cardiol Date: 2020-03-24 Impact factor: 24.094